Evaluation of a new hydroxyethyl starch solution (HES 130/0.4) in patients undergoing preoperative autologous blood donation.

Kasper, S M; Strömich, A; Kampe, S; Radbruch, L

Kasper, S M; Strömich, A; Kampe, S; Radbruch, L.

Affiliation

Kasper SM; Department of Anesthesiology, University of Cologne, 50924 Cologne, Germany. stefan-mario.kasper@medizin.uni-koeln.de

J Clin Anesth ; 13(7): 486-90, 2001 Nov.

Article in En | MEDLINE | ID: mdl-11704445

Subject(s)

Blood Transfusion, Autologous; Hydroxyethyl Starch Derivatives/pharmacology; Adult; Aged; Blood Loss, Surgical/prevention & control; Double-Blind Method; Female; Hemodynamics/drug effects; Humans; Hydroxyethyl Starch Derivatives/adverse effects; Male; Middle Aged; Solutions

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Hemoterapia Main subject: Blood Transfusion, Autologous / Hydroxyethyl Starch Derivatives Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Clin Anesth Year: 2001 Type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links